Back in December 2017, Benefits Canada assembled some noted Consultants and top advisors to spend an afternoon talking about Pharmacare. I was privileged to be part of this group. As one of my colleagues noted in a Twitter post after the event, we did not break any new ground, but we all emerged with a better understanding of the the challenges and opportunities that stand in the way of meaningful action on a National Pharmacare strategy.